Medicare Enrolled
Dr. Gregory Dilimetin, MD
Nephrology · Bellmore, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dilimetin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dilimetin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dilimetin
Dr. Gregory Dilimetin is a nephrology specialist in Bellmore, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Dilimetin performed 17,011 Medicare services across 1,717 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dilimetin received a total of $10,035 from 35 pharmaceutical and/or device companies across 440 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nephrology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dilimetin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 1% volume in NY
$10,035 industry payments
Medicare Practice Summary
Medicare Utilization ↗17,011
Medicare services
Top 1% in NY for nephrology
1,717
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~851 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
12,000 | $0 | $1 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
1,120 | $6 | $21 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
762 | $72 | $211 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
282 | $77 | $389 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
200 | $8 | $10 |
| Dialysis services for patients 20 or older Dialysis treatment provided to patients aged 20 years or older, involving four or more physician visits per month. |
172 | $326 | $1,052 |
| Iron level test | 151 | $6 | $16 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
150 | $10 | $26 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
150 | $13 | $34 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
150 | $9 | $22 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
148 | $8 | $19 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
147 | $13 | $33 |
| Parathyroid hormone level test A blood test that measures the amount of parathyroid hormone in your body. This hormone helps regulate calcium levels in the blood and bones. |
146 | $40 | $103 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
145 | $7 | $17 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
144 | $29 | $74 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
143 | $10 | $24 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
121 | $5 | $13 |
| Urine total protein level A laboratory test that measures the total amount of protein present in a urine sample. |
121 | $4 | $9 |
| Urine microalbumin test (kidney screening) A laboratory test that measures the amount of microalbumin, a small protein, in a urine sample. This test is used to detect early signs of kidney damage. |
120 | $6 | $14 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
102 | $159 | $589 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
98 | $15 | $38 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
97 | $14 | $37 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
60 | $34 | $128 |
| Hemodialysis, single evaluation A dialysis procedure to filter waste from the blood, performed with a physician's evaluation. |
51 | $65 | $213 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
47 | $110 | $544 |
| PSA test (prostate cancer screening) | 43 | $18 | $46 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
39 | $13 | $42 |
| LDL cholesterol level test A blood test that measures the amount of low-density lipoprotein (LDL) cholesterol in your blood. LDL is often referred to as "bad" cholesterol. |
34 | $10 | $26 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
28 | $16 | $42 |
| Dialysis services for adults, 2-3 visits per month This code covers dialysis services for patients aged 20 or older who have 2 to 3 physician visits per month. |
26 | $273 | $875 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
14 | $65 | $276 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$10,035
Total received (2018-2024)
Avg $1,434/year across 7 years
Top 12% in NY for nephrology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
440
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,731 (97.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$304 (3.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,937
2023
$1,579
2022
$1,405
2021
$1,755
2020
$808
2019
$1,344
2018
$1,206
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Mallinckrodt Hospital Products Inc.
$286
Amgen Inc.
$247
AstraZeneca Pharmaceuticals LP
$225
Novo Nordisk Inc
$212
Otsuka America Pharmaceutical, Inc.
$147
ANI Pharmaceuticals, Inc.
$144
GlaxoSmithKline, LLC.
$141
Boehringer Ingelheim Pharmaceuticals, Inc.
$100
Bayer Healthcare Pharmaceuticals Inc.
$83
Novartis Pharmaceuticals Corporation
$82
Fresenius USA Marketing, Inc.
$62
Lilly USA, LLC
$58
Aurinia Pharma U.S., Inc.
$54
CALLIDITAS THERAPEUTICS US INC.
$44
AKEBIA THERAPEUTICS INC
$32
Ardelyx, Inc.
$20
Top 3 companies account for 39.1% of 2024 payments
All-time payments by company (2018-2024) ›
Otsuka America Pharmaceutical, Inc.
$1,252
AstraZeneca Pharmaceuticals LP
$1,019
Amgen Inc.
$867
Horizon Therapeutics plc
$845
Mallinckrodt Hospital Products Inc.
$710
GlaxoSmithKline, LLC.
$598
Fresenius USA Marketing, Inc.
$565
AKEBIA THERAPEUTICS INC
$496
Vifor Pharma, Inc.
$451
OPKO Pharmaceuticals, LLC
$408
Novo Nordisk Inc
$318
Aurinia Pharma U.S., Inc.
$308
Relypsa, Inc.
$295
ANI Pharmaceuticals, Inc.
$258
Horizon Pharma plc
$212
Bayer Healthcare Pharmaceuticals Inc.
$185
Bayer HealthCare Pharmaceuticals Inc.
$161
Boehringer Ingelheim Pharmaceuticals, Inc.
$135
Novartis Pharmaceuticals Corporation
$109
Takeda Pharmaceuticals U.S.A., Inc.
$106
Mallinckrodt Enterprises LLC
$100
Alexion Pharmaceuticals, Inc.
$70
CALLIDITAS THERAPEUTICS US INC.
$65
Cumberland Pharmaceuticals, Inc.
$64
Keryx Biopharmaceuticals, Inc.
$58
Lilly USA, LLC
$58
Mallinckrodt LLC
$55
Exeltis, USA Inc.
$47
Travere Therapeutics, Inc.
$47
Ardelyx, Inc.
$44
Shire North American Group Inc
$39
Calliditas Therapeutics US Inc.
$27
Ultragenyx Pharmaceutical Inc.
$25
Hologic Sales and Service, LLC
$20
Daiichi Sankyo Inc.
$17
Top 3 companies account for 31.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AURYXIA · Auryxia · BENLYSTA · CRYSViTA · FARXIGA · GATTEX · IBSRELA · INJECTAFER · JARDIANCE · JYNARQUE · KORSUVA · KRYSTEXXA · Kerendia · LOKELMA · LUPKYNIS · MYOSURE TISSUE REMOVAL DEVICE · Ozempic · PURIFIED CORTROPHIN GEL · Parsabiv · RAYALDEE · Rayaldee · Rayaldee (old) · Rivfloza · Rybelsus · SAMSCA · TARPEYO · TAVNEOS · TERLIVAZ · ULTOMIRIS · Uloric · VAPRISOL DEXTROSE IN PLASTIC CONTAINER · Vaprisol · Vaprisol Dextrose in Plastic Container · Velphoro · Veltassa · Wegovy · XIGDUO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Nephrologists within 10 mi
525
Per 100K population
37.8
County median income
$143,408
Nearest hospital
NASSAU UNIVERSITY MEDICAL CENTER
3.5 mi
3.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dilimetin is a mixed practice specialist, with above-average Medicare volume (top 1% in NY), with low-engagement industry engagement in the top 12% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dilimetin experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Dilimetin performed 12,000 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dilimetin receive payments from pharmaceutical companies?
Yes. Dr. Dilimetin received a total of $10,035 from 35 companies across 440 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dilimetin's costs compare to other nephrologists in Bellmore?
Dr. Dilimetin's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dilimetin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Nephrology
Common procedures, typical costs, and what industry payments mean in nephrology.
Same specialty & city
Nephrologists in Bellmore
Browse nephrologists in Bellmore ranked by procedure volume and transparency data.
Highest volume
Top Nephrologists in NY
Nephrologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Nephrologists in NY
Which NY nephrologists receive the most from drug and device companies.
By company
Otsuka America Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Otsuka America Pharmaceutical, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology